Intermediate clinical endpoints for surrogacy in localised prostate cancer: an aggregate meta-analysis

Overview of attention for article published in Lancet Oncology, March 2021

Altmetric Badge

About this Attention Score

In the top 5% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (95th percentile)
Good Attention Score compared to outputs of the same age and source (66th percentile)

Mentioned by

twitter: 90 X users

Readers on

mendeley: 85 Mendeley

So far, Altmetric has seen 98 X posts from 90 X users, with an upper bound of 303,868 followers.

@seanmmcbride @DrSpratticus @DanLinMD @declangmurphy @aleberlin2 Haven't we all agreed that BCR is not a surrogate for OS for prostate cancer? Work from @LGharzai @DrSpratticus et al https://t.co/RdcI5g9DZp

RT @TheLancetOncol: NEW online: Intermediate clinical #endpoints for #surrogacy in localised #prostatecancer: an aggregate meta-analysis #p…

RT @arkhaki: @OncoAlert Great work by @DrSpratticus et al. in evaluating surrogacy of prostate Ca endpts (important for trial design and ap…

This page shows the most recent X posts that mention this research output. Click here to find out how to access more activity, including 94 additional X posts.